Meet One-on-One with...The Gates Foundation

Add this event to your calendar:
19/02/2015 13:30 19/02/2015 18:00 America/Los_Angeles Meet One-on-One with...The Gates Foundation Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA 94080 JLABS Bay Area false DD/MM/YYYY

Meet One-on-One with...The Gates Foundation

Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA 94080

February 19, 2015 from 13:30 PM to 18:00 PM (PST)

$10 - $35

JLABS BAY AREA EVENT Congratulations! You have been approved to attend a one-on-one meeting with The Gates Foundation. To secure your time slot please register your team who will be in attendance. After receiving confirmation of your registration you will be notified of your meeting time slot.

Note: Two registrations are required in order to attend the presentation & lunch, and the one-on-one meeting. After registering here for your one-on-one meeting, and if you have not done so yet, please register at

What does it take to save a life? The Bill & Melinda Gates Foundation Global Health Division aims to harness advances in science and technology to save lives in developing countries. The Foundation works with partners to deliver proven tools - including vaccines, drugs, and diagnostics - as well as discover path-breaking new solutions that are affordable and reliable. Focus areas for investments center on infectious diseases including HIV, polio, TB, dengue and malaria, as well as diagnostics and health IT ideas that bring health interventions to those who need them most. 

Bob More, Head of Venture Investing at the Gates Foundation will be in attendance on Thursday, February 19th to provide an overview presentation on the Foundation's key areas of interest and best practices when applying for funding. The Gates Foundation has made $3.6 billion in grant payments in 2013 with a total of $31.6 billion in grant payments since its inception. 

Bob will be on hand to meet with a handful of applicants one-on-one. 

10:30am | Registration and Networking
11:00am | Presentation and Q&A 
11:45am | Networking Lunch 
12:30-5:00pm | One-on-one Meetings* 

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ended on January 14th. 

 Bill & Melinda Gates Foundation Participating Representative:
Bob More | Head of Venture Investing, Bill & Melinda Gates Foundation read bio» 

Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until February 18th (or full). 

One-on-One Meeting
FREE | Application
FREE | Accepted Companies 
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ended on January 14th. Your application will be reviewed and you will be notified of acceptance by January 30, 2015. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved. 

329 Oyster Point Blvd, 3rd Floor
South San Francisco, California 

Bill & Melinda Gates Foundation Representative's Biography:
 Bob MoreBob More | Head of Venture Investing, Bill & Melinda Gates Foundation 
Bob More is the head of venture investing for the Bill & Melinda Gates Foundation and leads the Global Health Venture Initiative. Prior to his current position, More was a general partner at Frazier Healthcare and a member of the firm's Biopharma Venture Team. His other previous positions include partner at Domain Associates, a Kauffman Fellow, chief operating officer of Small Molecule Therapeutics, and positions at Pharmacia Biotech, Somatogen, and MedVest. More serves as an advisory board member for Greenspring Associates, Okapi Ventures, BioMed Realty Trust, The Medical Industry Group of the NVCA, and The Sulpizio Family Cardiovascular Center. He received a master of business administration degree from the Darden School of Business Administration at the University of Virginia and a bachelor of arts from Middlebury College. 


Connect with Bob:    Connect on LinkedIn Connect on Twitter




About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Thomas McNerney & Partners, NCATS, Poliwogg, and OrbiMed.

JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit or follow @JNJInnovation.

Event contact

Related content